Energy and Commerce Chairmen Waxman and Stupak Request FDA Review of Bisphenol A (BPA) Decision
Energy and Commerce Committee Chairman Henry A. Waxman and Oversight and Investigations Subcommittee Chairman Bart Stupak sent a letter to FDA Commissioner Margaret Hamburg relating to the possible dangers of Bisphenol A (BPA), a chemical found in consumer products and food product containers, particularly in infant formula containers and other items used by infants and children. Chairmen Waxman and Stupak asked Commissioner Hamburg to reconsider the FDA's conclusion under the Bush Administration that BPA is safe at current estimated exposure levels.
"It is critical that we know for certain whether BPA is safe to use in consumer products and food product containers," said Chairman Waxman. "We need to make sure that FDA thoroughly and fairly reviews the best science on BPA so that the public - and especially infants and children - are protected."
"The Subcommittee's concerns with BPA and the methods used to review its safety were raised repeatedly with the Bush Administration's FDA," said Subcommittee Chairman Stupak. "The new leadership at the FDA should conduct an immediate review of not only the safety of BPA but also the agency's interaction with industry groups in making the previous determination that BPA was safe. News of an industry meeting last week to discuss ways to block restrictions on BPA suggest industry has little interest in scientific facts or the public health. The FDA's reliance on industry studies in determining BPA's safety must be re-evaluated in light of clear signs industry is willing to mislead the American people on this public health issue."
Chairmen Waxman and Stupak also sent a document request to the North American Metal Packaging Alliance, the industry group that represents companies that manufacture and use BPA, regarding media reports that the group may use "fear tactics" in its public relations strategy to counter efforts to regulate BPA.
- 1 of 97